topiramate 50 MG Oral Capsule
topiramate
RxCUI: 252413
What the CMS Formulary Data Shows for topiramate 50 MG Oral Capsule
Per the CMS 2026 Part D formulary file, topiramate 50 MG Oral Capsule (RxNorm concept RXCUI 252413, generic name topiramate) appears on 211 distinct formulary files spanning 4,041 Medicare Part D plan offerings - 79.8% of enrollable Part D products, mid-range placement; shopping across contracts changes access. Tier placement ranges from Tier 1 to Tier 4, with a cross-plan average of Tier 2.5.
Real-world access to topiramate 50 MG Oral Capsule depends on utilization management as much as tier placement: 2.8% of covering formularies require prior authorization. 0% require step therapy. 0% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 644,196 Part D beneficiaries filled topiramate 50 MG Oral Capsule in 2023, with total plan-and-beneficiary spending of $56,441,529 and an average per-beneficiary annual cost of $87.62. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry topiramate 50 MG Oral Capsule today.
Coverage Details
- Formularies covering
- 211
- Plans covering
- 4,041
- Coverage rate
- 79.8%
- Tier range
- Tier 1 – Tier 4
- Average tier
- Tier 2, Generic
Restrictions
- Prior authorization required
- 2.8% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 0% of formularies
2023 Medicare Spending
- Beneficiaries
- 644,196
- Total spending
- $56,441,529
- Avg per beneficiary
- $87.62
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering topiramate 50 MG Oral Capsule
100 Medicare Advantage plans with Part D drug coverage include this drug.
Frequently Asked Questions
Is topiramate 50 MG Oral Capsule covered by Medicare Part D?
Yes, topiramate 50 MG Oral Capsule is covered by 4,041 Medicare Part D plans (79.8% of all Part D formularies).
What tier is topiramate 50 MG Oral Capsule on Medicare Part D plans?
topiramate 50 MG Oral Capsule averages Tier 2.5 across Part D plans, ranging from Tier 1 to Tier 4.
Does topiramate 50 MG Oral Capsule require prior authorization?
2.8% of Part D formularies require prior authorization for topiramate 50 MG Oral Capsule. Step therapy: 0%. Quantity limits: 0%.
How much does Medicare spend on topiramate 50 MG Oral Capsule?
In 2023, total Medicare Part D spending on topiramate 50 MG Oral Capsule was $56,441,529, covering 644,196 beneficiaries. The average spend per beneficiary was $87.62.
Read our methodology - how this data is sourced, computed, and verified.